Showing results (221-230 of 901) with videos related to
Sort By:
Pageof 91
European Journal of Gastroenterology & Hepatology|September 14, 2018
Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn's diseaseJulian Essmann, Carsten Keil, Olesya Unruh, et al.United European Gastroenterology Journal|May 6, 2020
Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitisMartha M Kirstein, Thorsten Book, Michael P Manns, et al.Journal of Virology|July 29, 2004
Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutantsFrank Tacke, Christina Gehrke, Tom Luedde, et al.Journal of Molecular Medicine (Berlin, Germany)|April 27, 2002
The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease componentsArndt Vogel, Christian P Strassburg, Petra Obermayer-Straub, et al.The Journal of Pediatrics|June 24, 2005
Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseasesTim O Lankisch, Christian P Strassburg, Dominique Debray, et al.Clinical Transplantation|May 10, 2007
Clinical relevance of autoantibodies after pediatric liver transplantationAndrea Richter, Enke Grabhorn, Knut Helmke, et al.Vaccine|March 10, 2012
Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccinationChristoph S Klade, Elisabeth Schuller, Thomas Boehm, et al.Zeitschrift Fur Gastroenterologie|October 19, 2021
[Glecaprevir/Pibrentasvir + Sofosbuvir + Ribavirin as a salvage regimen after Sofosbuvir + Velpatasvir + Voxilaprevir re-treatment failure]Tammo L Tergast, Nikolaus Kordecki, Valerie Ohlendorf, et al.United European Gastroenterology Journal|September 4, 2020
UEG framework for the development of high-quality clinical guidelinesDoron Boltin, Doenja Mj Lambregts, Fiona Jones, et al.Journal of Viral Hepatitis|March 16, 2023
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNAKatja Deterding, Chengjian Xu, Kerstin Port, et al.Pageof 91